SKIN vs. SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, SMLR, TMCI, and DCTH
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.
Beauty Health vs. Its Competitors
SiBone (NASDAQ:SIBN) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.
98.1% of SiBone shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 41.0% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Beauty Health has a net margin of -6.13% compared to SiBone's net margin of -12.83%. SiBone's return on equity of -14.20% beat Beauty Health's return on equity.
In the previous week, Beauty Health had 16 more articles in the media than SiBone. MarketBeat recorded 18 mentions for Beauty Health and 2 mentions for SiBone. Beauty Health's average media sentiment score of 0.95 beat SiBone's score of 0.62 indicating that Beauty Health is being referred to more favorably in the news media.
Beauty Health has higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
SiBone currently has a consensus price target of $23.00, indicating a potential upside of 51.12%. Beauty Health has a consensus price target of $2.81, indicating a potential upside of 88.76%. Given Beauty Health's higher probable upside, analysts plainly believe Beauty Health is more favorable than SiBone.
SiBone has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.
Summary
Beauty Health beats SiBone on 11 of the 16 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
This page (NASDAQ:SKIN) was last updated on 10/16/2025 by MarketBeat.com Staff
